Clinical Utility of Haloperidol in 51 State Hospital Admissions
Abstract
The author conducted an open clinical investigation of the therapeutic effectiveness and safety of haloperidol used alone or concomitantly with electrocoma therapy. A total of 51 men with affective psychoses were studied. Marked or moderate response to therapy was observed in 18 of 23 patients who received haloperidol alone, and 27 of 28 patients who received both haloperidol and ECT. Forty-four of the patients were discharged within 90 days following the initiation of the study; 41 have been followed clinically for a year and only six have required rehospitalization.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
